Trial Outcomes & Findings for Benefits of Applying Neuroprosthesis to Improve Grasping and Reaching in Spinal Cord Injury Patients (NCT NCT00221117)

NCT ID: NCT00221117

Last Updated: 2018-07-24

Results Overview

Functional Independent Measure was employed to measure the degree of disability for daily self care. It capture data on self-care, sphincter management, transfers,locomotion,communication,and social cognition.The scale is divided according to no helper category (level 6 and 7) where no other person is required to help with the activity and a hel;per category(level 1 through 5)where the patient needs minimal to total assistance from another person to accomplish the activity Score range from 18-126. Higher values represent a better outcome.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

22 participants

Primary outcome timeframe

35 min

Results posted on

2018-07-24

Participant Flow

Subjects were randomized using 2 sets of sealed envelopes. Each unmarked envelope contained a single sheet of paper with a printed number in the range of 1 to 40. A second set of envelopes was marked with numbers from 1 to 40 and contained a single sheet specifying the group allocation.

If participant did not meet inclusion criteria they would be excluded

Participant milestones

Participant milestones
Measure
Conventional Occupational Therapy-Control Group
Conventional occupational therapy pertaining to hand function represents control activities against which the FES therapy was assessed. The conventional occupational therapy included: a) muscle facilitation exercises emphasizing the neurodevelopmental treatment approach; b) task-specific, repetitive functional training; c) strengthening and motor control training using resistance to available arm motion to increase strength; d) stretching exercises; e) electrical stimulation applied primarily for muscle strengthening (this is not FES but TENS application); f) activities of daily living including self-care where the upper limb was used as an assist if appropriate; and g) caregiver training.
Fes Therapy-Treatment Group
The FET began by designing stimulation protocols to generate power (circular grip and lateral pinch) and precision (opposition with 2 and 3 fingers) grasps on demand. The stimulation sequence (protocol) for power and precision grasps was developed for each patient individually using the Compex Motion electric stimulator. Compex Motion is a fully programmable transcutaneous (surface) stimulator that uses self-adhesive surface electrodes.
Overall Study
STARTED
12
9
Overall Study
COMPLETED
12
9
Overall Study
NOT COMPLETED
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Benefits of Applying Neuroprosthesis to Improve Grasping and Reaching in Spinal Cord Injury Patients

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Conventional Occupational Therapy-Control Group
n=12 Participants
Conventional occupational therapy pertaining to hand function represents control activities against which the FES therapy was assessed. The conventional occupational therapy included: a) muscle facilitation exercises emphasizing the neurodevelopmental treatment approach; b) task-specific, repetitive functional training; c) strengthening and motor control training using resistance to available arm motion to increase strength; d) stretching exercises; e) electrical stimulation applied primarily for muscle strengthening (this is not FES but TENS application); f) activities of daily living including self-care where the upper limb was used as an assist if appropriate; and g) caregiver training.
Fes Therapy-Treatment Group
n=9 Participants
The FET began by designing stimulation protocols to generate power (circular grip and lateral pinch) and precision (opposition with 2 and 3 fingers) grasps on demand. The stimulation sequence (protocol) for power and precision grasps was developed for each patient individually using the Compex Motion electric stimulator. Compex Motion is a fully programmable transcutaneous (surface) stimulator that uses self-adhesive surface electrodes.
Total
n=21 Participants
Total of all reporting groups
Age, Categorical
<=18 years
0 Participants
n=5 Participants
1 Participants
n=7 Participants
1 Participants
n=5 Participants
Age, Categorical
Between 18 and 65 years
11 Participants
n=5 Participants
7 Participants
n=7 Participants
18 Participants
n=5 Participants
Age, Categorical
>=65 years
1 Participants
n=5 Participants
1 Participants
n=7 Participants
2 Participants
n=5 Participants
Age, Continuous
44.75 years
STANDARD_DEVIATION 4.72 • n=5 Participants
43.2 years
STANDARD_DEVIATION 5.45 • n=7 Participants
43.975 years
STANDARD_DEVIATION 5.085 • n=5 Participants
Sex: Female, Male
Female
3 Participants
n=5 Participants
2 Participants
n=7 Participants
5 Participants
n=5 Participants
Sex: Female, Male
Male
9 Participants
n=5 Participants
7 Participants
n=7 Participants
16 Participants
n=5 Participants
Region of Enrollment
Canada
12 participants
n=5 Participants
9 participants
n=7 Participants
21 participants
n=5 Participants

PRIMARY outcome

Timeframe: 35 min

Functional Independent Measure was employed to measure the degree of disability for daily self care. It capture data on self-care, sphincter management, transfers,locomotion,communication,and social cognition.The scale is divided according to no helper category (level 6 and 7) where no other person is required to help with the activity and a hel;per category(level 1 through 5)where the patient needs minimal to total assistance from another person to accomplish the activity Score range from 18-126. Higher values represent a better outcome.

Outcome measures

Outcome measures
Measure
FES Therapy
n=9 Participants
The Functional Independence Measure (FIM)15 was employed to measure the degree of disability for daily self-care.
Conventional Occupational Therapy
n=12 Participants
The Functional Independence Measure (FIM)15 was employed to measure the degree of disability for daily self-care.
Functional Independence Measure (FIM)
20.1 units on a scale
Standard Deviation 9.87
10 units on a scale
Standard Deviation 9.065

SECONDARY outcome

Timeframe: 45 min

Population: The subject's impairment and demographic characteristics were analyzed using descriptive statistics for parametric and nonparametric data.

The Toronto Rehabilitation Institute Hand Function Test (TRI-HFT) evaluates gross motor function of unilateral grasp (also referred to as the Rehabilitation Engineering Laboratory Hand Function Test). Hand functions that are assessed with TRI-HFT include the following: lateral or pulp pinch and palmar grasp.Score range from 0-70. Higher values represent a better outcome.

Outcome measures

Outcome measures
Measure
FES Therapy
n=9 Participants
The Functional Independence Measure (FIM)15 was employed to measure the degree of disability for daily self-care.
Conventional Occupational Therapy
n=12 Participants
The Functional Independence Measure (FIM)15 was employed to measure the degree of disability for daily self-care.
Rehabilitation Engineering Laboratory Hand Function Test(REL Test)
16.7 units on a scale
Standard Deviation 14.80
11.3 units on a scale
Standard Deviation 9.52

SECONDARY outcome

Timeframe: 30 min

Score range from 0-100. Higher score represent a better outcome.

Outcome measures

Outcome measures
Measure
FES Therapy
n=9 Participants
The Functional Independence Measure (FIM)15 was employed to measure the degree of disability for daily self-care.
Conventional Occupational Therapy
n=12 Participants
The Functional Independence Measure (FIM)15 was employed to measure the degree of disability for daily self-care.
Spinal Cord Independence Measure (SCIM).
10.1 units on a scale
Standard Deviation 3.8
3.1 units on a scale
Standard Deviation 2.4

Adverse Events

Control Group

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Fes Therapy-Treatment Group

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dr. Milos Popovic

Toronto RI Institute

Phone: 416-597-3422

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place